Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Cardiac Biomarkers Testing Market Grown from 2024 to 2025?

In recent times, the size of the cardiac biomarkers testing market has seen significant expansion. It is projected to surge from $13.48 billion in 2024 to $15.09 billion in 2025, with a compound annual growth rate (CAGR) of 12.0%. The accelerating growth during the historic period is linked to the rising occurrences of cardiovascular diseases, the aging demographic, educational and awareness programs, governmental regulations and healthcare policies, as well as the uptick in healthcare spending.

What Growth Rate Is Anticipated for the Cardiac Biomarkers Testing Market in the Coming Years?

The size of the cardiac biomarkers testing market is predicted to experience substantial growth in the coming years, and is anticipated to reach $23.75 billion in 2029 with a compound annual growth rate (CAGR) of 12.0%. Factors contributing to this growth during the prediction period include the advent of personalized medicine, a surge in global cardiovascular disease incidences, the utilization of artificial intelligence (AI) in diagnostics, the growth of point-of-care testing, and a growing focus on early disease detection. Key trends projected during this period involve technological advancements, progresses in AI-assisted diagnostics, the expansion of point-of-care testing (POCT), the ability to perform multiplexing, as well as progress in biomarker discovery and verification.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9436&type=smp

Who Are the Leading Companies in the Cardiac Biomarkers Testing Market?

Major companies operating in the cardiac biomarkers testing market include Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Biomérieux SA, Becton Dickinson and Company, Randox Laboratories Ltd., Enzo Biochem Inc., Creative Diagnostics Inc., Merck Co. & KGaA, Beckman Coulter Inc., QIAGEN N.V., PerkinElmer Inc., Tosoh Corporation, Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc., DIALAB GmbH, CardioGenics Holdings Inc., Lepu Medical Technology (Beijing) Co. Ltd., Biosynex SA, Charles River Laboratories, Quidel Corporation, Life Diagnostics, Trinity Biotech plc, Guangzhou Wondfo Biotech Co. Ltd., Nova Biomedical Corp., Ortho Clinical Diagnostics Inc., Sekisui Diagnostics Inc., Abcam plc, Bio-Techne Corporation

What Are the Key Drivers of the Cardiac Biomarkers Testing Market?

The growth of the cardiac biomarkers testing market is projected to be fueled by the escalating occurrence of cardiovascular diseases. These diseases predominantly affect the heart or blood vessels. Cardiac biomarker tests are critical in measuring biomarker levels for immediate detection and assessment of a heart attack’s severity and scale. Consequently, the rising prevalence of cardiovascular diseases is expected to amplify the need for cardiac biomarker testing solutions. For example, in August 2022, the American College of Cardiology, a professional medical organization based in the US, forecasted a significant rise in incidence rates of cardiovascular risk factors and disease in the United States by 2060. Hence, the growing prevalence of cardiovascular diseases is propelling the cardiac biomarkers testing market expansion.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9436&type=smp

What Are the Key Market Segments in the Cardiac Biomarkers Testing Industry?

The cardiac biomarkers testing market covered in this report is segmented –

1) By Biomarkers Type: Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarkers Types

2) By Application: Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications

3) By End-User: Hospitals, Specialty Clinics

Subsegments:

1) By Creatine Kinase (CK-MB): Total CK-MB, CK-MB Mass

2) By Troponins: Cardiac Troponin I (cTnI), Cardiac Troponin T (cTnT)

3) By Myoglobin: Total Myoglobin

4) By Natriuretic Peptides: B-Type Natriuretic Peptide (BNP), N-Terminal Pro B-Type Natriuretic Peptide (NT-ProBNP)

5) By Ischemia Modified Albumin (IMA): IMA Levels

6) By Other Biomarkers Types: C-Reactive Protein (CRP), Heart-Type Fatty Acid-Binding Protein (H-FABP), Soluble ST2

What Are the Latest Trends in the Cardiac Biomarkers Testing Market?

In the cardiac biomarker testing market, leading enterprises are establishing strategic partnerships so to enable early detection of heart-related warning signs and enhance patient results. Cardiac biomarker testing collaborations foster synergy between companies, promoting the invention of cutting-edge diagnostics, broadening market penetration, and fast-tracking the supply of sophisticated testing solutions for enhanced cardiovascular treatment. For example, in September 2024, MediBuddy, a healthcare technology firm based in India that offers a comprehensive telehealth services, health management, and insurance assistance platform, formed alliance with Philips, a conglomerate corporation headquartered in the Netherlands. The aim of this collaboration is to elevate cardiac care in India through the integration of Philips’ HeartPrint technology, which allows regular tracking and risk evaluation of heart health. This progressive strategy equips users with state-of-the-art tools on the MediBuddy platform, encouraging proactive heart health management and improved outcomes.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

What Are the Key Regional Markets in the Cardiac Biomarkers Testing Industry?

North America was the largest region in the cardiac biomarkers testing market in 2024. The regions covered in the cardiac biomarkers testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9436

This Report Delivers Insight On:

1. How big is the cardiac biomarkers testing market, and how is it changing globally?

2. Who are the major companies in the cardiac biomarkers testing market, and how are they performing?

3. What are the key opportunities and risks in the cardiac biomarkers testing market right now?

4. Which products or customer segments are growing the most in the cardiac biomarkers testing market?

5. What factors are helping or slowing down the growth of the cardiac biomarkers testing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model